Non-pharmacological Interventions for People With Mild Cognitive Impairment in the Community (CNPI-MCI)
11 juli 2026 uppdaterad av: Yiran Yue, Anhui Medical University
Development of a 'Community-Family Mutual Support' Intervention Model for Patients With Mild Cognitive Impairment Based on Social Support Theory
Mild cognitive impairment (MCI) may increase the risk of dementia.
This study will evaluate an 8-week community-family mutual support intervention for adults aged 60 years or older with MCI.
Participants will be randomly assigned to an intervention group or a control group.
The control group will receive routine community care, while the intervention group will additionally receive cognitive training, health education, family support, mutual support activities, and individualized feedback.
Cognitive function, daily functioning, emotional status, and social support will be assessed before and after the intervention.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Beräknad)
70
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Yiran Yue
- Telefonnummer: 8617333266696
- E-post: yueyiran1@163.com
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Aged 60 years or older.
- Meets the diagnostic criteria for mild cognitive impairment, including subjective cognitive decline, objective impairment in at least one cognitive domain, relatively preserved activities of daily living, and no diagnosis of dementia.
- Has lived in the study community for at least 6 months.
- Has completed primary school or above and is able to read and write.
- Is able to communicate and complete the study assessments and intervention activities.
- Voluntarily participates and provides written informed consent.
Exclusion Criteria:
- Unable to communicate effectively.
- Has severe visual or hearing impairment that prevents participation.
- Has dementia, schizophrenia, or another severe psychiatric disorder.
- Has a serious or unstable physical illness that prevents participation in the intervention.
- Is currently participating in another cognitive training or similar intervention study.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Community-Family Mutual Support Intervention
Participants will receive routine community care plus an 8-week community-family mutual support intervention based on social support theory.
The intervention includes health education, cognitive training, emotional self-monitoring, family involvement, mutual support between participating families, group activities, and individualized feedback.
|
Participants will receive an 8-week community-family mutual support intervention in addition to routine community care.
Guided by social support theory, the program integrates informational, emotional, instrumental, and appraisal support.
It includes MCI-related health education, cognitive training, physical activity guidance, emotional self-monitoring, home-based practice with family assistance, mutual support between paired families, group activities, and individualized feedback.
The intervention will be delivered through community-based sessions and supported home activities by trained researchers and community nurses.
|
|
Aktiv komparator: Routine Community Care
Participants will receive routine community care, including standard health education and usual community-based health services, during the 8-week study period.
They will not receive the community-family mutual support intervention.
|
Participants will receive routine community care, including standard health education and usual community-based health services, during the 8-week study period.
They will not receive the community-family mutual support intervention.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Change in Cognitive Function Assessed by the Montreal Cognitive Assessment (MoCA)
Tidsram: From enrollment to the end of treatment at 8 weeks
|
From enrollment to the end of treatment at 8 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change From Baseline in Social Support Rating Scale (SSRS) Total Score
Tidsram: From enrollment to the end of treatment at 8 weeks
|
Social support will be assessed using the 10-item Social Support Rating Scale (SSRS).
The total score ranges from 12 to 66 points, with higher scores indicating greater social support.
The outcome measure is the change in the total score from baseline to Week 8.
|
From enrollment to the end of treatment at 8 weeks
|
|
Change From Baseline in Patient Health Questionnaire-9 (PHQ-9) Total Score
Tidsram: From enrollment to the end of treatment at 8 weeks
|
Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9).
Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27.
Higher scores indicate more severe depressive symptoms.
The outcome measure is the change in the PHQ-9 total score from baseline to Week 8.
|
From enrollment to the end of treatment at 8 weeks
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
28 juli 2026
Primärt slutförande (Beräknad)
28 september 2026
Avslutad studie (Beräknad)
28 oktober 2026
Studieregistreringsdatum
Först inskickad
7 juli 2026
Först inskickad som uppfyllde QC-kriterierna
11 juli 2026
Första postat (Faktisk)
14 juli 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
14 juli 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
11 juli 2026
Senast verifierad
1 juli 2026
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 81251000 (Annat bidrag/finansieringsnummer: Biomedical Ethics Committee of Anhui Medical University)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .